Pharmacokinetics of Nadolol, a Beta‐Receptor Antagonist: Administration of Therapeutic Single‐ and Multiple‐Dosage Regimens to Hypertensive Patients
- 12 November 1979
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 19 (11) , 712-720
- https://doi.org/10.1002/j.1552-4604.1979.tb01641.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).Published by Wiley ,1979
- Preclinical toxicologic evaluation of nadolol, a new β-adrenergic antagonistToxicology and Applied Pharmacology, 1978
- Metabolic Studies in Patients with Nadolol: Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1977
- Clinical Pharmacokinetics of β-Adrenoreceptor BlockersDrugs, 1976
- Anti-arrhythmic action of nadolol, a β-adrenergic receptor blocking agentEuropean Journal of Pharmacology, 1976
- Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depressionEuropean Journal of Pharmacology, 1975